Pre-beta release of AnnotationPress with drug interaction annotations for public comment

#1

I am pleased to announce that we are hosting a pre-beta release of our new scientific annotation tool called AnnotationPress. This is a limited version of the tool provided with the goal show interested persons the unique approach to scientific annotation provided by the system. We welcome questions and feedback using this forum.

Please login by the public account to see existing annotations and play around with creating new ones (Email: test@gmail.com password: testtest).

AnnotationPress is designed to provide a user friendly tool that helps scientists annotate scientific claims, data, and evidence in HTML or PDF documents. The current version works only with pre-loaded HTML documents and is configured to annotated drug-drug interactions in both full text journal articles and structured product labeling. This is a particularly challenging domain that required the development of several annotation workflows which we think will be useful for for other scientific domains. We plan another pre-beta release in February 2017 that will provide PDF annotation features. Planned milestones and known issues can be found at the project’s github site..

We have created 3 introductory videos describing our our AnnotationPress tool and showing the annotation of drug-drug interaction evidence items:

A key aspect of AnnotationPress is its use of annotation plug-ins which make the tool is easily adaptable to other annotation use cases. Another distinctive feature is that AnnotationPress implements the Micropublication and Open Annotation data standards. These standards specify how to relate annotations in target documents about data, methods, and materials to scientific claims.

Over the next few months we plan to release more short videos on the following topics:

  1. introducing the overall vision of AnnotationPress, its approach to evidence-based scientific discourse, how its data architecture supports publishing micro and nanopublications,

  2. How annotators can enter negated statements and evidence that refutes a scientific claim

  3. How developers can create new wizards for new annotation use cases

  4. How drug biocurators can annotate case reports and associate a drug interaction probabily scale (DIPS) evaluation.

  5. How drug biocurators can annotate drug phenotype studies

Happy New Year!
Rich Boyce and the AnnotationPress team.

0 Likes

#2

Congrats team!

I was just showing wireframes to a colleague today – I was so excited to be able to share this post, and to look at the demos.

0 Likes